Greiner Bio-One invests in a new high-bay warehouse at its Frickenhausen site
Frickenhausen, 27 April 2017 – Greiner Bio-One GmbH is constructing a new high-bay warehouse at its home base in Frickenhausen. The new 29-metre-high construction will replace the current high-bay warehouse, which is no longer capable of dealing with the greatly increased warehouse technology and capacity requirements. The building is part of an infrastructure project that also includes plans for developing additional production space. The ground-breaking ceremony for the new high-bay warehouse was held today, Thursday, and it is scheduled for completion in April 2018.
Five times faster – more than twice as much space
Greiner Bio-One specialises in the development, production and sale of high-quality plastic laboratory products. Its 1980s high-bay warehouse was no longer able to keep pace with the dynamic growth the company has undergone in the last few years. It was close to full capacity at times, and stock had to be stored at other sites. The new building will double the number of pallet spaces to more than 12,000. With a volume of 70,000 cubic metres, there is – theoretically – easily space to park 7,000 compact cars in the building.
Warehouse technology has evolved radically in recent decades. The digital revolution is also driving a technological transformation. This alone made a modernisation of the facility inevitable. The new fully-automatic high-bay warehouse will improve material flows and productivity in logistics. It will in future be possible to move five times as much material in and out of storage in the same period of time.
Major infrastructure project launches
However, the company is not only investing in the plant infrastructure to improve material supply and logistics, it is also significantly expanding its production capacity at the same time. In the next two years, for example, the production areas at the Frickenhausen site will be expanded by a third to a total of 5,200 square metres. The addition of 14 more system positions will then bring the total number to 61. The next few years will also see a further 40 employees added to the existing staff of 330. All in all, the company is investing more than eleven million euros in the comprehensive renovation of the Frickenhausen site.
Clear commitment to Germany as an industrial location
„Efficient logistics and production are more than an investment in competitiveness for us,“ CEO Heinz Schmid explained at the ground-breaking ceremony for the new high-bay warehouse. „Systematically expanding the site is also a promise to our customers that we will continue manufacturing high-quality products „Made in Germany“ at this site.“ The whole project therefore represents a clear commitment to Germany as an industrial location on the part of Greiner Bio- One.
Link to the webcam on the high-bay warehouse construction site:
Greiner Bio-One International GmbH
Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions – Preanalytics, BioScience and Sterilisation. In 2015, Greiner Bio-One International GmbH generated a turnover of 427 million euros and had over 1,890 employees, 23 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner Holding, which is based in Kremsmünster (Austria).
Greiner Bio-One BioScience Division
The BioScience division of Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures. Drawing on decades of experience with cryogenic sample storage, Greiner Bio-One also offers solutions for automated storage systems in biobanks. In addition, we continue to utilise our expertise in the development and production of microplates for high-throughput screening, thereby allowing extremely fast and efficient drug screening for both industrial and research applications. The entire development, manufacturing and sales operations are controlled from the German headquarters of the BioScience division in Frickenhausen.